Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects

Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy... Clin Drug Investig (2017) 37:861–871 DOI 10.1007/s40261-017-0546-8 ORIGINAL RESEARCH ARTICLE Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects 1 1 1 1 2 • • • • • Chaoying Hu Yijun Wang Rong Song Chen Yu Xiaoyan Luo Jingying Jia Published online: 10 July 2017 Springer International Publishing AG 2017 Abstract (AUC) and C values increased approximately dose max Background and Objective The pharmacokinetics of proportionally. Lurasidone steady state was achieved after lurasidone have been studied in healthy Japanese and 5 days of daily dosing and the accumulation index of the Caucasian subjects, but not in Chinese subjects. The AUC during a dosage interval (AUC ) was 1.25, smaller objective of this study was to evaluate the pharmacoki- than theoretical cumulative coefficient (1.76). Similar netics, safety, and tolerability of oral lurasidone in healthy results were observed for the metabolites (ID-14283, ID- Chinese subjects. 14326, and ID-11614). No severe adverse events (AEs) Methods This single-center, randomized, parallel-group, were observed in the single- or multiple-dose studies and placebo-controlled, and double-blind study evaluated the no subject discontinued from the study due to AEs. The pharmacokinetics, safety, and tolerability of oral lurasidone most common reported AEs were somnolence, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Drug Investigation Springer Journals

Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects

Loading next page...
 
/lp/springer_journal/single-and-multiple-dose-pharmacokinetics-safety-and-tolerability-of-8VMJPgZvm5
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
1173-2563
eISSN
1179-1918
D.O.I.
10.1007/s40261-017-0546-8
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial